AKYA Akoya Biosciences, Inc.: מכפיל P/S עתידי

Akoya Biosciences (AKYA) generates revenue through the sale of PhenoCycler systems and associated reagents. Demand for tumor protein analysis tools is driven by pharmaceutical centers and research institutes. The forward P/S trajectory based on GURU.Markets data demonstrates the influence of these factors, where the 0.80 level captures the current state. The company's environmental profile is based on electronics recycling and office energy efficiency.

This indicator assesses investment reliability via the ratio of market capitalization to expected revenue, filtering out short-term volatility by smoothing price fluctuations. By analyzing the forward P/S ratio, an investor can identify the potential for multiple compression, which in the case of Akoya Biosciences (AKYA) is offset by a "razor-and-blade" model, where equipment sales guarantee a steady stream of high-margin revenue from the sale of consumables.